The ADVOR Trial: Acetazolamide in Acute Decompensated Heart Failure
REBEL EM
SEPTEMBER 15, 2022
Background: Patients presenting with acute exacerbations of congestive heart failure are frequently treated with intravenous loop diuretics. Despite being treated with loop diuretics, the problem is many are discharged from the hospital with residual clinical signs of volume overload despite optimal treatment. One option to improve diuresis may be the addition of acetazolamide, however evidence supporting this strategy is sparse.
Let's personalize your content